Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | NGVT | Common Stock | Options Exercise | $142K | +5.18K | +20.44% | $27.38 | 30.5K | May 7, 2021 | Direct | |
transaction | NGVT | Common Stock | Sale | -$444K | -5.18K | -16.97% | $85.76 | 25.3K | May 7, 2021 | Direct | F1 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | NGVT | Employee Stock Option (right-to-buy) | Options Exercise | $0 | -5.18K | -100% | $0.00* | 0 | May 7, 2021 | Common Stock | 5.18K | $27.38 | Direct |
Id | Content |
---|---|
F1 | The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $85.47 to $85.96, inclusive. The reporting person undertakes to provide to Ingevity Corporation, any security holder of Ingevity Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |